Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Auricular neuromodulation for veterans with fibromyalgia

Official title: Auricular Neuromodulation in Veterans With Fibromyalgia: A Randomized, Sham-Controlled Study

Run by VA Office of Research and Development · NCT06415591 · Data updated 2026-11-12

This study is testing if a new ear-based treatment can help veterans with fibromyalgia feel less pain and move better compared to a fake treatment.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment240 (estimated)
SponsorVA Office of Research and Development
Federal
Locations1 site (Decatur, Georgia)
StatusRecruiting
StartedNovember 1, 2024
Main results expectedSeptember 1, 2028
Study endsNovember 1, 2028
Registry record updatedMay 22, 2026
Trial IDNCT06415591 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include veterans aged 18 and older with a diagnosis of fibromyalgia and a pain score of 4 or greater.

Probably not a fit

Patients who are pregnant, have a history of seizures or neurological conditions, or are claustrophobic may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study evaluates the effectiveness of percutaneous electrical nerve field stimulation (PENFS), a non-pharmacologic therapy, in treating fibromyalgia among veterans. The approach targets cranial nerve branches through the external ear to alleviate pain and improve physical function. The study will utilize resting state functional connectivity MRI to assess changes in brain activity associated with treatment. By comparing PENFS to a sham treatment, the study aims to rigorously test its efficacy and understand the underlying mechanisms of its effects.

Why it matters

Potential benefit: If successful, this treatment could significantly improve pain management and quality of life for veterans suffering from fibromyalgia.

How similar studies have gone: Previous studies have shown promising results for similar non-pharmacologic approaches, indicating potential for success in this trial.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age 18 years or older; for those who participate in the MRI portion, age 20-60 years old (limit specifically set for participants receiving an MRI scan; limit set to minimize brain structural changes due to aging)
* For those who participate in the MRI portion, right-handedness, to provide consistency in brain structure and function (limit specifically set for participants receiving an MRI scan; limit set to minimize brain structural changes due to aging)
* For those who participate in the MRI portion, the ability to safely tolerate MRI
* Diagnosis of fibromyalgia by the American College of Rheumatology 2016 criteria69
* Pain score of 4 or greater on DVPRS51 in the 3 months prior to enrollment
* Intact skin in area of PENFS treatment

Exclusion Criteria:

* Pregnancy (self-reported)
* History of seizures or neurologic conditions that alter the brain
* Claustrophobia, MRI-incompatible implants, or other conditions incompatible with MRI (only for those who participate in MRI)
* History of uncontrolled psychiatric illness, autoimmune disease that leads to pain, or skin conditions that can increase risk of infection at PENFS site

Where it's running

  • Atlanta VA Medical and Rehab Center, Decatur, GA
    Decatur, Georgia, United States
    Recruiting

Study contacts

  • Principal investigator: Anna Woodbury, MD — Atlanta VA Medical and Rehab Center, Decatur, GA
  • Study coordinator: Anna Woodbury, MD
  • Email: Anna.Woodbury@va.gov
  • Phone: (404) 321-6111

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.